Michael Mahoney

MICHAEL MAHONEY is president and chief executive officer of Boston Scientific Corporation and a member of the company’s board of directors. Mahoney oversees global development, marketing and sales of the company’s broad medical solutions portfolio. He assumed this role in November 2012, after serving one year as president of Boston Scientific, leading the cardiac rhythm management (CRM) and endoscopy (GI and Pulmonary) business divisions. Mahoney joined the company in October 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses. Prior to Boston Scientific, Mahoney served as worldwide chairman of Johnson & Johnson’s medical devices and diagnostics (MD&D) division, overseeing seven franchises and 50,000 employees. He previously served as worldwide group chairman of Johnson & Johnson’s DePuy orthopedics and neuro-sciences business. Mahoney was president and CEO of global healthcare exchange (GHX), a leading supply chain solutions company. He built GHX through organic development, seven strategic acquisitions and expanding into Canada and Europe. Mahoney serves on AdvaMed’s board of directors and is a member of the American Heart Association CEO Roundtable. He earned a B.B.A. in finance from the University of Iowa and his M.B.A. from Wake Forest University. @bostonsci